Follow POL on Twitter Beck and Herrmann give a good overview of the three big cases pending in the Supreme Court (one which awaits cert) and substantial coverage of the recent Third Circuit argument in Colacicco.
FDA preemption in the courts
Related Entries:
- Greg Conko: Can brand makers be sued for generic drug injuries?
- Romney and self-deporting
- Another lawless jackpot award over propofol in Nevada
- Douglas v. Independent Living Center of Southern California
- Rehearing sought in Mensing
- Around the web, June 5
- Somin on federalism and tort reform
- Martin Act abuses
- "Abnormal Use" interview
- Lasker on preemption
- Around the web, March 28
- Teva and Baxter appeal $505 million Nevada propofol verdict
- Breaking: unanimous vote against preemption in Williamson v. Mazda
- Tort reform and federalism
- Regulatory creep in action
 |
| Isaac Gorodetski Project Manager, Center for Legal Policy at the Manhattan Institute igorodetski@manhattan-institute.org |
 |
| Bridget Carroll Press Officer, Manhattan Institute bcarroll@manhattan-institute.org |
